<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The complement system is essential in the pathogenesis of inflammatory central <z:mp ids='MP_0008912'>nervous</z:mp> system disorders </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate the involvement of complement pathways in <z:e sem="disease" ids="C0027873" disease_type="Disease or Syndrome" abbrv="">neuromyelitis optica</z:e> (<z:chebi fb="0" ids="52093">NMO</z:chebi>), levels of breakdown products for classical (C4d), alternative (FBb) and common (sC5b-9) pathways were measured in the sera of 28 NMO and control patients (30 Beh√ßet's disease (BD), 29 multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (MS)) and 31 healthy controls by ELISA </plain></SENT>
<SENT sid="2" pm="."><plain>Classical and/or alternative pathway consumption was enhanced in <z:chebi fb="0" ids="52093">NMO</z:chebi> and BD patients as compared to MS patients and healthy controls </plain></SENT>
<SENT sid="3" pm="."><plain>Our results suggest that NBD and <z:chebi fb="0" ids="52093">NMO</z:chebi> differ from MS by the predominance of complement system involvement </plain></SENT>
</text></document>